Prognostic importance of dyspnea for cardiovascular outcomes and mortality in persons without prevalent cardiopulmonary disease: The atherosclerosis risk in communities study

PLoS ONE

Volumn 11, Issue 10, 2016, Pages

  Santos, Mario ^a,b   Kitzman, Dalane W ^c   Matsushita, Kunihiro ^d   Loehr, Laura ^e   Sueta, Carla A ^e   Shah, Amil M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b University of Porto   (Portugal)

^c WAKE FOREST BAPTIST HEALTH   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; COMMUNITY ASSESSMENT; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HUMAN; INCIDENCE; LUNG DISEASE; MALE; MODIFIED MEDICAL RESEARCH COUNCIL SCALE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREVALENCE; PROGNOSIS; RACE; RATING SCALE; SELF REPORT; SEX DIFFERENCE; SMOKING; MIDDLE AGED; MORTALITY; PULMONARY HEART DISEASE;

DYSPNEA; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PULMONARY HEART DISEASE;

EID: 84992426995     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0165111     Document Type: Article

References (22)

1. Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012; 185(4):435-52. Epub 2012/02/18. doi: 10.1164/rccm. 201111-2042ST PMID: 22336677.
2. Gronseth R, Vollmer WM, Hardie JA, Olafsdottir IS, Lamprecht B, Buist AS, et al. Predictors of dyspnoea prevalence: results from the BOLD study. Eur Respir J. 2014; 43(6):1610-20. Epub 2013/11/02. doi: 10.1183/09031936.00036813 PMID: 24176991; PubMed Central PMCID: PMC4143752.
3. Banzett RB, O'Donnell CR. Should we measure dyspnoea in everyone? The European respiratory journal. 2014; 43(6):1547-50. Epub 2014/06/02. doi: 10.1183/09031936.00031114 PMID: 24881053; PubMed Central PMCID: PMC4096708.
4. Frostad A, Soyseth V, Andersen A, Gulsvik A. Respiratory symptoms as predictors of all-cause mortality in an urban community: a 30-year follow-up. J Intern Med. 2006; 259(5):520-9. Epub 2006/04/25. doi: 10.1111/j.1365-2796.2006.01631.x PMID: 16629856.
5. Rosengren A, Wilhelmsen L. Respiratory symptoms and long-term risk of death from cardiovascular disease, cancer and other causes in Swedish men. Int J Epidemiol. 1998; 27(6):962-9. Epub 1999/02/19. PMID: 10024189.
6. Sorlie PD, Kannel WB, O'Connor G. Mortality associated with respiratory function and symptoms in advanced age. The Framingham Study. Am Rev Respir Dis. 1989; 140(2):379-84. Epub 1989/08/01. doi: 10.1164/ajrccm/140.2.379 PMID: 2764375.
7. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002; 121(5):1434-40. Epub 2002/05/15. PMID: 12006425.
8. Abidov A, Rozanski A, Hachamovitch R, Hayes SW, Aboul-Enein F, Cohen I, et al. Prognostic significance of dyspnea in patients referred for cardiac stress testing. The New England journal of medicine. 2005; 353(18):1889-98. Epub 2005/11/04. doi: 10.1056/NEJMoa042741 PMID: 16267320.
9. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation. 2001; 104(23):2855-64. Epub 2001/12/06. PMID: 11733407.
10. Brancati FL, Kao WH, Folsom AR, Watson RL, Szklo M. Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. Jama. 2000; 283 (17):2253-9. Epub 2000/05/12. PMID: 10807384.
11. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol. 1989; 129(4):687-702. Epub 1989/04/01. PMID: 2646917.
12. Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J. 1959; 2(5147):257-66. Epub 1959/08/29. PMID: 13823475; PubMed Central PMCID: PMC1990153.
13. Folsom AR, Yamagishi K, Hozawa A, Chambless LE. Absolute and attributable risks of heart failure incidence in relation to optimal risk factors. Circ Heart Fail. 2009; 2(1):11-7. Epub 2009/10/08. doi: 10. 1161/CIRCHEARTFAILURE.108.794933 PMID: 19808310; PubMed Central PMCID: PMC2637354.
14. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9):604-12. Epub 2009/05/06. PMID: 19414839; PubMed Central PMCID: PMC2763564.
15. White AD, Folsom AR, Chambless LE, Sharret AR, Yang K, Conwill D, et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J Clin Epidemiol. 1996; 49(2):223-33. Epub 1996/02/01. PMID: 8606324.
16. Loehr LR, Rosamond WD, Chang PP, Folsom AR, Chambless LE. Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol. 2008; 101(7):1016-22. Epub 2008/03/25. doi: 10.1016/j.amjcard.2007.11.061 PMID: 18359324.
17. Bell EJ, Lutsey PL, Windham BG, Folsom AR. Physical activity and cardiovascular disease in African Americans in Atherosclerosis Risk in Communities. Med Sci Sports Exerc. 2013; 45(5):901-7. Epub 2012/12/19. doi: 10.1249/MSS.0b013e31827d87ec PMID: 23247714; PubMed Central PMCID: PMC3622814.
18. Kroenke K, Arrington ME, Mangelsdorff AD. The prevalence of symptoms in medical outpatients and the adequacy of therapy. Arch Intern Med. 1990; 150(8):1685-9. Epub 1990/08/01. PMID: 2383163.
19. van Mourik Y, Rutten FH, Moons KG, Bertens LC, Hoes AW, Reitsma JB. Prevalence and underlying causes of dyspnoea in older people: a systematic review. Age Ageing. 2014; 43(3):319-26. Epub 2014/01/30. doi: 10.1093/ageing/afu001 PMID: 24473156.
20. Gerlach Y, Williams MT, Coates AM. Weighing up the evidence:a systematic review of measures used for the sensation of breathlessness in obesity. Int J Obes (Lond). 2013; 37(3):341-9. Epub 2012/04/26. doi: 10.1038/ijo.2012.49 PMID: 22531088.
21. Carlsson AC, Arnlov J, Sundstrom J, Michaelsson K, Byberg L, Lind L. Physical activity, obesity and risk of cardiovascular disease in middle-aged men during a median of 30 years of follow-up. Eur J Prev Cardiol. 2015. Epub 2015/01/22. doi: 10.1177/2047487314568034 PMID: 25604741.
22. Murad K, Kitzman DW. Frailty and multiple comorbidities in the elderly patient with heart failure: implications for management. Heart Fail Rev. 2012; 17(4-5):581-8. Epub 2011/06/01. doi: 10.1007/s10741-011-9258-y PMID: 21626426; PubMed Central PMCID: PMC3804644.